Insulin sensitivity predicts cognitive decline in individuals with prediabetes

Abstract

IntroductionEpidemiological studies indicate an association between type 2 diabetes and cognitive dysfunction that appear to start already in the prediabetic state. Although cross-sectional studies have linked insulin resistance to impaired cognition, the potential predictive value of insulin resistance has not yet been sufficiently studied longitudinally without confounding by overt diabetes (and its pharmacological treatment).Research design and methodsWe investigated longitudinal data from participants of the ‘Tübinger Evaluation of Risk Factors for Early Detection of Neurodegeneration’ Study. Subjects underwent a neurocognitive assessment battery (CERAD Plus battery; Consortium to Establish a Registry for Alzheimer’s Disease) at baseline and followed every 2 years (median follow-up 4.0 Q1–3: 2.2–4.3 years). Subjects within a pre-diabetic glycated hemoglobin range of 5.6%–6.5% underwent 5-point 75 g oral glucose tolerance tests (OGTTs) with assessment of insulin sensitivity and insulin secretion (n=175). Subjects with newly diagnosed diabetes mellitus or with major depressivity (Beck Depression Inventory >20) were excluded (n=15). Data were analyzed by mixed models using sex, age and glycemic trait as fixed effects. Subject and time since first measurement were used as random effects.ResultsInsulin sensitivity was positively associated with the CERAD sum score (higher is better) in a time-dependent manner (p=0.0057). This result is mainly driven by a steeper decrease in the memory domain associated with lower insulin sensitivity (p=0.029). The interaction between age and insulin sensitivity was independent of glycemia (p=0.02). There was also no association between insulin secretion and cognition.ConclusionsInsulin resistance rather than sole elevation of blood glucose predicts cognitive decline, specifically in the memory domain, in persons with prediabetes. Treatments of diabetes that improve insulin sensitivity might therefore have the potential to postpone or even prevent cognitive decline in patients with diabetes.

The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study

“…Prediabetes and glycemic variability are better known for their impact on the peripheral nervous system, however, recent papers have revealed interesting findings concerning the impact of prediabetes on brain amyloid accumulation and cognitive abilities ( 20 , 21 ). The majority of the described reports discuss diseases other than PSP/CBS, however, they may be useful in understanding the underlying mechanisms that are likely also present in atypical tauopathic parkinsonian syndromes.…”

“…The metabolic evaluations were based on examinations using fluorodeoxyglucose in positron emission tomography. In a different study, prediabetes was associated with insulin resistance rather than solely based on the elevation of glucose levels in the context of cognitive deterioration ( 21 ). The literature concerning the correlation between prediabetes and brain abnormalities is limited.…”

Based on voxel-based morphological analysis to investigate the effect of acupuncture-rehabilitation therapy on hippocampal volume and its neuroprotective mechanism in patients with vascular cognitive impairment with type 2 diabetes mellitus

“…[ 13 ] Insulin resistance indicates a decline in cognitive ability mainly in the field of memory in patients with prediabetes. [ 14 ] Diabetes can also have a synergistic effect with hypertension and heart disease, increasing the risk of cognitive impairment in patients with cerebrovascular disease. [ 15 ]…”

Metabolic Syndrome, Cognitive Impairment and the Role of Diet: A Narrative Review

“…However, insulin resistance is not limited to peripheral tissues, with impaired insulin signaling being reported to affect the brain, as indicated by a decrease in protein kinase B phosphorylation in a variety of animal and cell models of insulin resistance [53]. Insulin resistance may represent a better predictor of memory impairment than elevated blood glucose, thereby providing further support to the role of insulin resistance as a key mechanism driving cognitive decline [54]. Thus, it appears clear that T2DM and AD share common features regarding insulin resistance and impaired brain glucose metabolism, which has led some investigators to refer to this neurodegeneration as type 3 diabetes [55].…”